Short synthetic glycopeptides successfully induce antibody responses to carcinoma-associated Tn antigen

Journal of Peptide Research

Volumn 55, Issue 2, 2000, Pages 173-180

  Vichier Guerre, S ^a   Lo Man, R ^a   Bay, S ^a   Deriaud, E ^a   Nakada, H ^b   Leclerc, C ^a   Cantacuzène, Danièle ^a  

^a INSTITUT PASTEUR   (France)

^b KYOTO SANGYO UNIVERSITY   (Japan)

Author keywords

Antigenicity; Glycopeptide; Immunogenicity; MLS 128; Tn antigen; Tumor associated antigen

Indexed keywords

B LYMPHOCYTE ANTIGEN; CANCER ANTIBODY; EPITOPE; GLYCOPEPTIDE; MONOCLONAL ANTIBODY; T LYMPHOCYTE ANTIGEN; TETANUS TOXIN; TUMOR ANTIGEN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOGENICITY; MOUSE; NONHUMAN; POLIOMYELITIS VIRUS; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, NEOPLASM; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CANCER VACCINES; CARCINOMA; FEMALE; GLYCOPEPTIDES; MICE; MICE, INBRED BALB C;

EID: 0033951772     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3011.2000.00167.x     Document Type: Article

References (49)

1. 1. Bhavanandan, V.P. (1991) Cancer-associated mucins and mucin-type glycoproteins. Glycobiology 1, 493-503.
2. 2. Fukuda, M. (1996) Possible roles of tumor-associated carbohydrate antigens. Cancer Res. 56, 2237-2244.
3. 3. Hakomori, S. (1989) Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv. Cancer Res. 52, 257-331.
4. 4. MacLean, G.D., Reddish, M.A., Bowen-Yacyshyn, M.B., Poppema, S. & Longenecker, B.M. (1994) Active specific immunotherapy against adenocarcinoma. Cancer Invest. 12, 46-56.
5. 5. Helling, F., Zhang, S., Shang, A., Adluri, S., Calves, M., Koganty, R., Longenecker, B.M., Yao, T.-J., Oettgen, H.F. & Livingston, P.O. (1995) GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21. Cancer Res. 55, 2783-2788.
6. 6. Fung, P.Y.S., Madej, M., Koganty, R.R. & Longenecker, B.M. (1990) Active specific immunotherapy of a murine mammary adenocarcinoma using a synthetic tumor-associated glycoconjugate. Cancer Res. 50, 4308-4314.
7. 7. MacLean, G.D., Bowen-Yacyshyn, M.B., Samuel, J., Meikle, A., Stuart, G., Nation, J., Poppema, S., Jerry, M., Koganty, R., Wong, T. & Longenecker, B.M. (1992) Active immunization of human ovarian cancer patients against a common carcinoma (Thomson-Friedenreich) determinant using a synthetic carbohydrate antigen. J. Immunother. 11, 292-305.
8. 8. Reddish, M.A., Jackson, L., Koganty, R.R., Qiu, D., Hong, W. & Longenecker, B.M. (1997) Specificities of an anti-sialyl-Tn and anti-Tn monoclonal antibodies generated using novel clustered synthetic glycopeptide epitopes. Glycoconjugate J. 14, 549-560.
9. 9. Lett, E., Klopfenstein, C., Klein, J.-P., Schöller, M. & Wachsmann, D. (1995) Mucosal immunogenicity of polysaccharides conjugated to a peptide or multiple-antigen peptide containing T- and B-cell epitopes. Infect. Immun. 63, 2645-2651.
10. 10. Bay, S., Lo-Man, R., Osinaga, E., Nakada, H., Leclerc, C. & Cantacuzene, D. (1997) Preparation of a multiple antigen glycopeptide (MAG) carrying the Tn antigen. J. Peptide Res. 49, 620-625.
11. 11. Posnett, D.N., McGrath, H. & Tam, J.P. (1988) A novel method for producing anti-peptide antibodies. J. Biol. Chem. 263, 1719-1725.
12. 12. Tam, J.P. (1988) Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc. Natl Acad. Sci. USA 85, 5409-5413.
13. 13. Leclerc, C., Deriaud, D., Mimic, V. & Van der Werf, S. (1991) Identification of a T-cell epitope adjacent to neutralization antigenic site 1 of poliovirus Type 1. J. Virol. 65, 711-718.
14. 14. Lo-Man, R., Bay, S., Vichier-Guerre, S., Deriaud, E., Cantacuzene, D. & Leclerc, C. (1999) A fully synthetic immunogen carrying a carcinoma-associated carbohydrate for active specific immunotherapy. Cancer Res. 59, 1520-1524.
15. 15. Numata, Y., Nakada, H., Fukui, S., Kitagawa, H., Ozaki, K., Inoue, M., Kawasaki, T., Funakoshi, I. & Yamashima, I. (1990) A monoclonal antibody directed to Tn antigen. Biochem. Biophys. Res. Commun. 170, 981-985.
16. 16. Nakada, H., Numata, Y., Inoue, M., Tanaka, N., Kitagawa, H., Funakoshi, I., Fukui, S. & Yamashima, I. (1991) Elucidation of an essential structure recognized by an anti-GalNAc-Ser (Thr) monoclonal antibody (MLS 128). J. Biol. Chem. 266, 12402-12405.
17. 17. Nakada, H., Inoue, M., Numata, Y., Tanaka, N., Kunakoshi, I., Fukui, S., Mellors, A. & Yamashina, I. (1993) Epitopic structure of Tn glycophorin A for an anti-Tn antibody (MLS 128). Proc. Natl Acad. Sci. USA 90, 2495-2499.
18. 18. Toyokuni, T., Dean, B., Cai, S., Boivin, D., Hakomori, S. & Singhal, A.K. (1994) Synthetic vaccines; synthesis of a dimeric Tn antigen-lipeptide conjugate that elicits immune responses against Tn-expressing glycoproteins. J. Am. Chem. Soc. 116, 395-396.
19. 19. McCool, D.J., Forstner, J.F. & Forstner, G.G. (1994) Synthesis and secretion of mucin by the human colonic tumor cell line LS 180. Biochem. J. 302, 111-118.
20. 20. Inoue, M., Nakada, H., Tanaka, N. & Yamashina, I. (1994) Tn antigen is expressed on leukosialin from T-lymphoid cells. Cancer Res. 54, 85-88.
21. 21. Toyokuni, T., Hakomori, S. & Singhal, A.K. (1994) Synthetic carbohydrate vaccines: synthesis and immunogenicity of Tn antigen conjugates. Bioorg. Med. Chem. 2, 1119-1132.
22. 22. Paulsen, H. & Hölck, J.-P. (1982) Synthese der glycopeptide O-β-D-galactopyranosyl-(1-3)-O-(2-acetamido-2-deoxy-α-D-galactopyranosyl)-(1-3)-L-serin und L-threonin. Carbohydr. Res. 109, 89-107.
23. 23. Paulsen, H. & Adermann, K. (1989) Synthesis von O-glycopeptid-sequenzen des N-terminus von Interleukin-2. Liebigs Ann. Chem. 751-759.
24. 24. Shafizadeh, F. (1963) D-galactal. Methods Carbohydr. Chem. 2, 409-410.
25. 25. Schultz, M. & Kunz, H. (1993) Synthetic glycopeptides as model substrates for glycosyltransferases. Tetrahedron Assym. 4, 1205-1220.
26. 26. Vowinkel, E. (1967) Darstellung von carbonsaüreestem mittels O-alkyl-N,N′-dicylohexyl-isoharnstoffen. Chem. Ber. 100, 16-22.
27. 27. Lemieux, R.U. & Ratcliffe, R.M. (1979) The azidonitration of tri-O-acetyl-D-galactal. Can. J. Chem. 57, 1244-1251.
28. 28. Ferrari, B.P.A. (1980) The synthesis of derivatives of 3-O-(2-acetamido-2-deoxy-α-D-galactopyranosyl)-L-serine and L-threonine. Carbohydr. Res. 79, C1-C7.
29. 29. Paulsen, H., Schultz, M., Klamann, J.-D., Waller, B. & Paal, M. (1985) Synthese von O-glycopeptid-blöcken des glycophorin. Liebigs Ann. Chem. 2028-2048.
30. 30. Knorr, R., Trzeciak, A., Bannwarth, W. & Gillessen, D. (1989) New coupling reagents in peptide chemistry. Tetrahedron Lett. 30, 1927-1930.
31. 31. Fields, C.G., Lloyd, D.H., Macdonald, R.L., Otteson, K.M. & Noble, R.M. (1991) HBTU activation for automated Fmoc solid-phase peptide synthesis. Peptide Res. 4, 95-101.
32. 32. Meldal, M. & Jensen, K.J. (1990) Pentafluorophenyl esters for the temporary protection of the α-carboxy group in solid phase glycopeptide synthesis. J. Chem. Soc., Chem. Commun. 483-485.
33. 33. Elofsson, M., Roy, S., Walse, B. & Kihlberg, I. (1993) Solid phase synthesis and conformational studies of glycosylated derivatives of helper-T-cell immunogenic peptides from hen egg lysozyme. Carbohydr. Res. 246, 89-103.
34. 34. Anisfeld, S.T. & Lansbury, P.T. (1990) A convergent approach to the chemical synthesis of asparagine-linked glycopeptides. J. Org. Chem 55, 5560-5562.
35. 35. Filira, F., Biondi, L., Cavaggion, F., Scolaro, B. & Rocchi, R. (1990) Synthesis of O-glycosylated tuftsins by utilizing threonine derivatives containing an unprotected monosaccharide moiety. Int. J. Peptide Protein Res. 36, 86-96.
36. 36. Kates, S.A., De la Tore, B.G., Eritja, R. & Albericio, F. (1994) Solid phase N-glycopeptide synthesis using allyl side-chain protected Fmoc-amino acids. Tetrahedron Lett. 35, 1033-1034.
37. 37. Otvos, L., Urge, L., Hollosi, M., Wroblewski, K., Graczyk, G., Fasman, G.D. & Thurin, J. (1990) Automated solid-phase synthesis of glycopeptides. Incorporation of unprotected mono and disaccharides units of N-glycoprotein antennae into T-cell epitopic peptides. Tetrahedron Lett. 31, 5889-5892.
38. 38. Reimer, K.B., Meldal, M., Kusumoto, S., Fukase, K. & Bock, K. (1993) Small-scale solid phase O-glycopeptide synthesis of linear and cyclized hexapeptides from bood clotting factor IX containing O-(α-D-Xyl-1-3-α-D-Xyl-1-3β-Glc)-L-Ser. J. Chem. Soc. Perkin Trans 1, 925-932.
39. 39. Urge, L., Gorbics, L. & Otvos, L. (1992) Chemical glycosylation of peptide T at natural and artificial glycosylation sites stabilizes or rearranges the dominant reverse turn structure. Biochem. Biophys. Res. Commun. 184, 1125-1132.
40. 40. Sjölin, P., Elofsson, M. & Kihlberg, J. (1996) Removal of acyl protective groups from glycopeptides: base does not epimerize peptide stereocenters and β-elimination is slow. J. Org. Chem. 61, 560-565.
41. 41. Inoue, M., Yamashina, I. & Nakada, H. (1998) Glycosylation of tandem repeat unit of the MUC2 polypeptide leading to the synthesis of the Tn antigen. Biochem. Biophys. Res. Commun. 245, 23-27.
42. 42. Brumeanu, T.D., Casares, S., Bot, A., Bot, S. & Bona, C.A. (1997) Immunogenicity of a contiguous T-B synthetic epitope of the A/PR/8/34 influenca virus. J. Virol. 71, 5473-5480.
43. 43. Del Guercio, M.E., Alexander, J., Kubo, R.T., Arrhenius, T., Maewal, A., Appella, E., Hoffman, S.I., Jones, T., Valmori, D., Sakaguchi, K., Grey, H.M. & Sette, A. (1997) Potent immunogenic short linear peptide constructs composed of B-cell epitopes and Pan DR T helper epitopes (PADRE) for antibody responses in vivo. Vaccine 15, 441-448.
44. 44. Obeid, O.E., Partidos, C.D., Howard, C.R. & Steward, M.W. (1995) Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus. J. Virol 69, 1420-1428.
45. 45. Partidos, C.D., Ripley, J., Delmas, A., Obeid, O.E., Denbury, A. & Steward, M.W. (1997) Fine specificity of the antibody response to a synthetic peptide from the fusion protein and protection against measles virus-induced encephalitis in a mouse model. J. Gen. Virology 78, 3227-3232.
46. 46. Meldal, M., Mouritsen, S. & Bock, K. (1993) In Carbohydrate Antigens, ACS Symposium Ser., Vol. 519 (P.J. Garegg & A.A. Lindberg, eds), Academic Press, New York, pp. 19-33.
47. 47. Chong, P., Chan, N., Kandil, A., Tripet, B., James, O., Yang, Y.-P., Shi, S.-P. & Klein, M. (1997) A strategy for rational design of fully synthetic glycopeptide conjugate vaccines. Infect. Immun. 65, 4918-4925.
48. 48. Kaumaya, P.T., Conrad, S.F., DiGeorge, A.M. & Lairmore, M.D. (1995) Glycosylation-dependent antgenic determinants of env gp46 HTLV-1. Leukemia 9, S133-S138.
49. 49. Reis, C.A., Sorensen, T., Mandel, U., David, L., Mirgorodskaya, E., Roepstorff, P., Kihlberg, J., Hansen, J.E. & Clausen, H. (1998) Development and characterization of an antibody directed to an alpha-N-acetyl-D-galactosamine glycosylated MUC2 peptide. Glycoconjugate J. 15, 51-62.